Cite
HARVARD Citation
Ferrante, M. et al. (n.d.). P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn's disease: Results from the EVOLVE Expansion study. Journal of Crohn's and colitis. pp. i768-i769. [Online].